Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Delox Air - Continuous air bio-decontamination compatible with human presence

Project description

Solution to effectively eliminate airborne pathogens

The pandemic underscored the critical importance of air quality for public health. Current technologies struggle to effectively control the spread of airborne pathogens. The challenge is to clean spaces while protecting people from microorganisms without relying on harsh chemicals. The EIC-funded DeloxAir project introduces the Delox AIR solution, which uses dryVHP technology to eliminate airborne pathogens with 99.99 % efficacy while consuming up to 20 % less energy than existing systems. Delox AIR is designed for use in nursing homes, hospitals, offices and governmental buildings. DeloxAir plans to complete development and validation providing a solution that addresses the need for effective aerosol decontamination in pandemic management, promoting social interaction and preventing disease spread.

Objective

We learned from the pandemic that air quality is essential for people’s health. Current technologies did not effectively manage infectious diseases propagated by aerosol suspensions of pathogens, leading to the need for social distancing and dramatically impacting the economy and people’s mental health. The challenge is not only cleaning the space but keeping people safe and free from microorganisms’ exposure without harming them with harsh chemicals.
Delox AIR solution will change the paradigm of bio-decontamination of airborne pathogens in occupied spaces, a disruptive factor in the market. Based on our proprietary dryVHP, Delox AIR can kill microorganisms in the air with 99.99% efficacy, ensuring 100% human safety and consuming up to 20% less energy than current systems. Delox AIR can be readily integrated into any HVAC systems for continuous air purification.
Delox AIR is part of the air purification market. We are targeting the commercial applications that capture the largest market (≈70% in 2021), accounting for €15.0 B by 2030. We will first target settings characterised by high occupancy density, presence of vulnerable individuals, and elevated risk of pathogen spread, such as nursing homes and hospitals, office spaces and educational and governmental buildings.
Our business model (B2B) is based on indirect sales through distributors already working in the sector that will easily reach HVAC consultants/contractors (customer) designing and delivering a turnkey HVAC system for the end-user.
We request EIC funding to complete the development of our system and validate it in three different types of closed environments. Our solution addresses the EIC Challenge of “Aerosol Decontamination for Pandemic Management”, satisfying the unmet need of facilitating social interaction and preventing disease spread.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2023-ACCELERATOR-01

See all projects funded under this call

Coordinator

DELOX - INVESTIGACAO, PROCESSOS E EQUIPAMENTOS CIENTIFICOS, LDA
Net EU contribution
€ 1 893 340,00
Address
TEC LABS CAMPUS DA FACULTADE DE CIENCIAS DA UNIVERSIDADE DE LISBOA, CAMPO GRANDE
1749-016 LISBOA
Portugal
SME
Yes
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 2 767 272,50